Ex-King Pharmaceutical Employee Loses Bid For Fees

Law360, New York (July 17, 2007, 12:00 AM EDT) -- An appeals court has blocked a former King Pharmaceuticals Inc. employee from seeking additional attorneys’ fees for his efforts in bringing a wide-scale whistleblower suit against the Bristol, Tenn.-based brand-name drug maker.

On Monday, the U.S. Court of Appeals for the Third Circuit affirmed a lower court’s decision that Edward Bogart was not entitled to an additional share of the settlements involving King and most of the U.S. states.

Bogart initiated the qui tam suit on behalf of the U.S., the District of Columbia and 10...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.